Merck & Co., Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
Merck & Co., Inc. (MRK) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $0 as of 2011-12-31, per its 10-K filed 2012-02-28.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2012-02-28
- 2011-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2011-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2011-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2011-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value as first filed |
|---|---|---|
| 2011-12-31 | $0.00 10-K · filed 2012-02-28 | |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $0.00 10-Q · filed 2011-11-08 | |
| 2011-03-31 | $0.00 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $13.00M 10-K · filed 2012-02-28 | |
| 2010-09-30 | $15.00M 10-Q · filed 2011-11-08 | $15.40M 10-Q · filed 2010-11-08 |
| 2010-06-30 | $17.00M 10-Q · filed 2011-11-08 | $17.10M 10-Q · filed 2010-08-06 |
| 2010-03-31 | $20.00M 10-Q · filed 2011-08-08 | $20.20M 10-Q · filed 2010-08-06 |
| 2009-12-31 | $72.00M 10-K · filed 2012-02-28 | $71.50M 10-Q · filed 2010-08-06 |
| 2009-09-30 | $35.70M 10-Q · filed 2010-11-08 | |
| 2009-06-30 | $42.10M 10-Q · filed 2010-08-06 | |
| 2009-03-31 | $75.00M 10-Q · filed 2010-08-06 | |
| 2008-12-31 | $97.00M 10-K · filed 2011-02-28 | $96.60M 10-Q · filed 2010-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |